Anson Funds Management’s Vivani Medical, Inc. Warrants expiring 03/14/2024 VANIW Stock Holding History

Anson Funds Management’s Portfolio VANIW Stock Details VANIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-166,945	Closed	-$2.54M	–	60
2018 Q3	$2.54M	Hold	166,945	–	–	0.91%	6
2018 Q2	$2.22M	Sell	166,945 -253	-0.2%	-$1.53K	1.3%	12
2018 Q1	$2.57M	Sell	167,198 -462	-0.3%	-$2.87K	1.91%	10
2017 Q4	$2.56M	Hold	167,660	–	–	1.73%	17
2017 Q3	$1.61M	Sell	167,660 -925	-0.5%	-$2.35K	0.24%	39
2017 Q2	$1.7M	Buy	+168,585	New	+$501K	0.54%	25

Other funds holding VANIW

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Anson Funds Management's VANIW Position: Q4 2018 in Review

Anson Funds Management sold out of Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) in Q4 2018, closing a stake of 166,945 shares — an estimated $2.54M sold.

Anson Funds Management first reported a position in VANIW in Q2 2017 and held it in 6 quarters. The position peaked at $2.57M in Q1 2018. 7 funds tracked by Wall St. Rank hold VANIW as of Q4 2018.

Anson Funds Management reported no remaining Vivani Medical, Inc. Warrants expiring 03/14/2024 position as of Q4 2018 after selling out during the quarter.
Anson Funds Management sold 166,945 Vivani Medical, Inc. Warrants expiring 03/14/2024 shares in Q4 2018, an estimated $2.54M.
Anson Funds Management first reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 in Q2 2017 and held it in 6 quarters.
Anson Funds Management's Vivani Medical, Inc. Warrants expiring 03/14/2024 position peaked at $2.57M in Q1 2018.
7 funds tracked by Wall St. Rank held Vivani Medical, Inc. Warrants expiring 03/14/2024 as of Q4 2018.

Based on Anson Funds Management's 13F filing for Q4 2018, filed 14 Feb 2019.